CalciMedica Inc. (CALC) Live Share Price, Invest From India

CalciMedica Inc. Stock Performance

as on June 18, 2026 at 6:59 am IST

Day's Low
Day's High
$0.84
Day's Price Range
$0.89
$0.85
1.18%
Downside
4.71%
Upside
52 Week's Low
52 Week's High
$0.46
52-Week Price Range
$7.20
$0.85
45.81%
Downside
747.06%
Upside

CalciMedica Inc. share price movements today

Previous Close: $0.86
Open: $0.88
Volume: 129.4K
Day's Low - High: $0.84 - $0.89
52 Week Low - High: $0.46 - $7.20

CalciMedica Inc. Historical Returns

1 Month Return: + 30.57 %
3 Month Return: + 2.94 %
1 Year Return: -49.23 %
3 Year Return: -82.94 %
5 Year Return: 0 %

CalciMedica Inc. Stock Fundamentals & Key Indicators

Check CalciMedica Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$13.7M

EPS (TTM)

-0.6167

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-22.2M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-399.51%

CalciMedica Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of CalciMedica Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
CalciMedica Inc.	BUY	$13.7M	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$38.4B	63.66%	72.49	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$114.3B	140.59%	26.73	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$64.5B	14.69%	15.02	29.65%	0.58%

Stock Returns calculator for CalciMedica Inc. Stock including INR - Dollar returns

The CalciMedica Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

CalciMedica Inc. investment value today

Current value as on today

₹55,064

Returns

-₹44,936

(-44.94%)

Returns from CalciMedica Inc. Stock

-₹49,704 (-49.7%)

Dollar Impact

₹4,768 (+4.77%)

Analyst Recommendation on CalciMedica Inc. Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for CalciMedica Inc.. Average target price of $10.33

CalciMedica Inc. Share Price Target

Get share price movements and forecasts by analysts on CalciMedica Inc..

What analysts predicted

91.77%UPSIDE

Target Price

$10.33

Current Price

$0.85

Analyzed by

10 Analysts

Target

$10.33

CalciMedica Inc. target price $10.33, a slight upside of 91.77% compared to current price of $0.85. According to 10 analysts rating.

Indian Investors' Interest in CalciMedica Inc. Stock

Search interest for CalciMedica Inc. Stock has decreased by -60% in the last 30 days, reflecting a downward trend in search activity.

Time period: May 19, 2026 to June 18, 2026

Change:-60% versus previous 30 day period

CalciMedica Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	0	-	-	-	-	-
Gross Profit	-	0	0	0	0	0	-	-	0	0
Operating Income	-4	-5	-6	-5	-6	-6	-6	-5	-4	-5
EBITDA	0	0	-3	-5	-4	-4	-5	-7	-10	5
Interest Expense	-	-	-	-	-	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-4	0	-3	-5	-4	-5	-5	-7	-10	4
Income Tax Expense	3	0	-	-	0	-	-	-	-	-
Net Income	-4	0	-3	-5	-4	-5	-5	-7	-10	4
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-7096.67%	0.00%	0.00%	0.00%	0.00%	0.00%

CalciMedica Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0
Operating Income	-37	-29	-35	-14	-38	-24	-23
EBITDA	-36	-29	-35	-7	-34	-13	-28
Interest Expense	-	0	0	0	0	-	1
Depreciation	0	0	0	0	0	0	0
Income Before Tax	-37	-27	-35	-7	-34	-13	-29
Income Tax Expense	0	0	-1	2	0	-	-
Net Income	-37	-27	-35	-7	-34	-13	-29
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

CalciMedica Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	0	-3	-5	-4	-5	-5	-7	-10	4
Operating Cash Flow	-4	-6	-4	-4	-4	-6	-4	-4	-4
Investing Cash Flow	-13	5	8	-5	-1	0	3	7	1
Financing Cash Flow	19	0	0	8	10	0	0	3	-
Change in Cash	1	-1	4	-1	4	-6	0	6	-3

CalciMedica Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-37	-27	-35	-7	-34	-13	-29
Operating Cash Flow	-31	-32	-31	-11	-25	-21	-21
Investing Cash Flow	-20	-42	10	0	8	-4	9
Financing Cash Flow	54	92	0	8	20	27	15
Change in Cash	3	17	-20	-3	4	2	3

Global Institutional Holdings in CalciMedica Inc.

Funds	Holdings
Summit Financial LLC	0.23%
Meritage Portfolio Management	0.39%
Stonehage Fleming Financial Services Holdings Ltd	0.34%
Jane Street Group LLC	1.13%
Deerfield Management Co	8.26%

See all

Insights on CalciMedica Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, CalciMedica, Inc. Common Stock has experienced a drawdown of -82.9%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 61.4%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 20.8% return, outperforming this stock by 70.0%
NEGATIVE IMPACT
Price Dip
In the last 7 days, CALC stock has moved down by -7.9%

About CalciMedica Inc.

CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.

Organisation	CalciMedica Inc.
Headquarters	505 Coast Boulevard South, La Jolla, CA, United States, 92037
Industry	Biotechnology
CEO	Dr. A. Rachel Leheny Ph.D.
E-voting on shares	Click here to vote

Key Management of CalciMedica Inc.

Name	Title
Dr. Sudarshan Hebbar M.D.	Chief Medical Officer
Dr. Stefan Feske M.D.	Co-Founder and Scientific Advisor
Mr. John M. Dunn J.D.	General Counsel
Dr. A. Rachel Leheny Ph.D.	CEO & Director
Mr. Michael J. Dunn B.A., M.B.A.	President & COO
Dr. Anjana Rao Ph.D.	Co-Founder and Scientific Advisor
Dr. Patrick Hogan Ph.D.	Co-Founder and Scientific Advisor
Dr. Kenneth A. Stauderman Ph.D.	Co-Founder & Chief Scientific Officer
Mr. Stephen B. Bardin	Chief Financial Officer
Mr. Eric W. Roberts	Chief Business Officer & Vice Chairman of the Board

FAQs

What is CalciMedica Inc. share price today?

CalciMedica Inc. share price today is $0.85 as on June 18, 2026 at 1:29 am IST at the close of the market. CalciMedica Inc. share today touched a day high of $0.89 and a low of $0.84.

What is the 52 week high and 52 week low for CalciMedica Inc. share?

CalciMedica Inc. share touched a 52 week high of $7.2 on January 2, 2026 and a 52 week low of $0.46 on March 2, 2026. CalciMedica Inc. stock price today i.e. June 18, 2026 at 1:29 am IST is closed at $0.85,which is 88.19% down from its 52 week high and 84.54% up from its 52 week low.

What is CalciMedica Inc.'s market capitalisation today?

CalciMedica Inc. market capitalisation is $0.00T as on June 18, 2026 at 1:29 am IST.

How to invest in CalciMedica Inc. Stock (CALC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for CalciMedica Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in CalciMedica Inc. Shares that will get you 1.7647 shares as per CalciMedica Inc. share price of $0.85 per share as on June 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy CalciMedica Inc. Stock (CALC) from India?

Indian investors can start investing in CalciMedica Inc. (CALC) shares with as little as ₹94.5 or $1 (as of June 18, 2026 at 1:49 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹945.00 in CalciMedica Inc. stock (as per the Rupee-Dollar exchange rate as on June 18, 2026 at 1:49 am IST). Based on CalciMedica Inc. share’s latest price of $0.85 as on June 18, 2026 at 1:29 am IST, you will get 11.7647 shares of CalciMedica Inc.. Learn more about fractional shares .